Novartis nabs Remicade biosimilar candidate off Pfizer in Europe
Sandoz has picked up the European rights to PF-06438179, a biosimilar of Remicade (infliximab), after Pfizer was forced to divest the candidate.
Archives for February 17, 2016
Merck & Co. to hire 200 across its Irish biomanufacturing operations
Looking for a job? Merck & Co. is hiring 200 in Ireland to support the manufacturing of its biologics and vaccines.
EMA advocates more regular MRIs for MS patients on Biogen’s mAb Tysabri
Multiple sclerosis patients taking Tysabri (natalizumab) who are deemed to be at high risk for the lethal infection PML should have regular brain scans according to the EMA.
Symbiosis growing on aseptic demand from US biotech
A robust investment environment and high quality demands have driven US biotech business to UK-based sterile manufacturer Symbiosis, the firm says.